# Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953

> **NCT00441987** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 96 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GSI-953

## Key facts

- **NCT ID:** NCT00441987
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2022-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00441987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00441987, "Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00441987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*